Moreover, preclinical and clinical studies have demonstrated that IL-2 can augment the development of immune cells, enhancing their abilities to eliminate cancer cells, particularly in renal cell carcinoma and malignant melanoma. The gene discussed is IL2; the disease is melanoma.